155 related articles for article (PubMed ID: 412282)
1. The influence of thiamin deficiency on the metabolism of the oral contraceptive mestranol [3-methoxy-17-ethynyl-1,3,5(10)-estratrien-17 beta-o1] by female rat liver enzymes.
Wade AE; Evans JS
Steroids; 1977 Aug; 30(2):275-83. PubMed ID: 412282
[TBL] [Abstract][Full Text] [Related]
2. Influence of the oral contraceptive, menstranol, on drug-metabolizing enzymes of female rats in thiamin-supplemented and deficiency states.
Wade AE; Evans JL; Seitz A
Pharmacology; 1976; 14(2):104-14. PubMed ID: 822434
[TBL] [Abstract][Full Text] [Related]
3. Influence of norethindrone on drug-metabolizing enzymes of female rat liver in various B-vitamin deficiency states.
Wade AE; Evans JS
Pharmacology; 1977; 15(4):289-301. PubMed ID: 408827
[TBL] [Abstract][Full Text] [Related]
4. Influence of dietary thiamin on phenobarbital induction of rat hepatic enzymes responsible for metabolizing drugs and carcinogens.
Wade AE; Evans JS; Holmes D; Baker MT
Drug Nutr Interact; 1983; 2(2):117-30. PubMed ID: 6432511
[TBL] [Abstract][Full Text] [Related]
5. Effects of oral contraceptive steroids (norethisterone/mestranol) on the activities of hepatic drug-metabolizing enzymes in iron-deficient anemic rats.
Mizokami K; Suzuki K; Inoue K; Sunouchi M; Hirakawa S; Goto S; Takanaka A; Kanke Y
Experientia; 1985 Jun; 41(6):734-6. PubMed ID: 3924648
[TBL] [Abstract][Full Text] [Related]
6. Induction of microsomal NADPH-cytochrome P-450 reductase and cytochrome P-450IVA1 (P-450LA omega) by dehydroepiandrosterone in rats: a possible peroxisomal proliferator.
Wu HQ; Masset-Brown J; Tweedie DJ; Milewich L; Frenkel RA; Martin-Wixtrom C; Estabrook RW; Prough RA
Cancer Res; 1989 May; 49(9):2337-43. PubMed ID: 2523237
[TBL] [Abstract][Full Text] [Related]
7. Effect of dietary lipid on drug-metabolizing enzymes.
Wade AE; Norred WP
Fed Proc; 1976 Nov; 35(13):2475-9. PubMed ID: 824158
[TBL] [Abstract][Full Text] [Related]
8. Effect of long-term therapy with an oral contraceptive on some aspects of hepatic lipid metabolism in vitro.
Weinstein I; Belitsky R; Seedman S; Friegly MJ; Trasher TN
Biochem Pharmacol; 1975 Sep; 24(17):1583-8. PubMed ID: 1191317
[TBL] [Abstract][Full Text] [Related]
9. Increased CYP1A2 content and capacity to activate Glu-P-1 and Trp-P-2 in liver microsomes of scorbutic ODS rats.
Mori T; Kitamura R; Imaoka S; Funae Y; Matsubara T; Kamataki T
Carcinogenesis; 1993 Dec; 14(12):2471-5. PubMed ID: 8269614
[TBL] [Abstract][Full Text] [Related]
10. Induction of microsomal drug metabolizing enzymes by oral contraceptives in protein-malnourished rats.
Sachan DS
J Nutr; 1976 Nov; 106(11):1569-76. PubMed ID: 824420
[TBL] [Abstract][Full Text] [Related]
11. Effect of oral contraceptive agents on nutrients: II. Vitamins.
Prasad AS; Oberleas D; Moghissi KS; Stryker JC; Lei KY
Am J Clin Nutr; 1975 Apr; 28(4):385-91. PubMed ID: 1168019
[TBL] [Abstract][Full Text] [Related]
12. Liver microsomes demethylation of mestranol (3-methoxy-17-ethynyl-1,3,5(10)-estratrien-17 -ol) and some of its effects on drug metabolism.
Lee SG; Chen C
Steroids; 1971 Nov; 18(5):565-75. PubMed ID: 4402245
[No Abstract] [Full Text] [Related]
13. Mechanism of induction of hepatic drug-metabolizing enzymes by ethanol-I. Limited role of microsomal phospholipids.
Joly JG; Hétu C; Mavier P; Villeneuve JP
Biochem Pharmacol; 1976 Sep; 25(17):1995-2001. PubMed ID: 825124
[No Abstract] [Full Text] [Related]
14. Alterations of hepatic microsomal drug metabolism by glucagon.
Aranda JV; Renton KW
Can J Physiol Pharmacol; 1975 Oct; 53(5):873-9. PubMed ID: 811338
[TBL] [Abstract][Full Text] [Related]
15. The effects of the continuous administration of N,N-dimethyl-4-phenylazoaniline (DAB) on the activities and the inducibilities of some drug-metabolizing enzymes in rat liver.
Autrup H; Thurlow BJ; Warwick GP
Chem Biol Interact; 1975 Nov; 11(5):313-28. PubMed ID: 148
[TBL] [Abstract][Full Text] [Related]
16. Hepatic drug metabolism in normal and vitamin E-deficient female Merino sheep.
Gourlay GK; Savage JK; Stock BH
Toxicol Appl Pharmacol; 1977 Mar; 39(3):365-75. PubMed ID: 404728
[No Abstract] [Full Text] [Related]
17. Decreased liver cytochrome P-450 in rats caused by norethindrone or ethynyloestradiol.
White IN; Muller-Eberhard U
Biochem J; 1977 Jul; 166(1):57-64. PubMed ID: 901418
[TBL] [Abstract][Full Text] [Related]
18. Hepatic cytochrome P-450 and in vitro drug metabolism in an overfed rat model of obesity.
Matsumoto RM; Jusko WJ; Corcoran GB
Drug Nutr Interact; 1988; 5(4):236-47. PubMed ID: 3149237
[TBL] [Abstract][Full Text] [Related]
19. Effect of aluminum on the hepatic mixed function oxidase and drug metabolism.
Bidlack WR; Brown RC; Meskin MS; Lee TC; Klein GL
Drug Nutr Interact; 1987; 5(1):33-42. PubMed ID: 3105994
[TBL] [Abstract][Full Text] [Related]
20. Effects of bromocriptine on hepatic cytochrome P-450 monooxygenase system.
Moochhala SM; Lee EJ; Hu GT; Koh OS; Becket G
Jpn J Pharmacol; 1989 Feb; 49(2):285-91. PubMed ID: 2499727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
